Journal article
Evidence for direct and sleep-moderated relationships between aquaporin-4 genetic variants and Alzheimer's disease phenotypes
Alzheimer's & dementia, Vol.22(6), e71516
2026
PMID: 42216479
Abstract
Introduction
Variants in the aquaporin-4 gene (AQP4) have been associated with Alzheimer's disease (AD) diagnosis, cognition, and brain amyloid beta (Aβ) and may affect the sleep and Aβ relationship. Their association with other AD-related phenotypes/disease progression remain largely unknown.
Methods
Associations between AQP4 variants, self-reported sleep measures, and AD-related phenotypes in cognitively unimpaired individuals with evidence of Aβ accumulation were examined using data from the Australian Imaging, Biomarkers and Lifestyle study.
Results
AQP4 variants were directly associated with regional brain volumes, atrophy, and cognition. They were also associated with differences in regional brain volumes and atrophy in interaction with sleep duration, latency, and quality. Finally, AQP4 variants were associated with cognitive decline in interaction with sleep disturbances.
Discussion
These findings support a relationship between AQP4 and AD phenotypes, both directly and through their interaction with sleep.
Highlights
∙ This was multimodal study of at-risk individuals integrating genetics, neuroimaging, cognition, and sleep.
∙ AQP4 genetic variants were associated with cognition, both directly and through interactions with sleep quality.
∙ Sleep duration, latency onset, and global quality consistently moderated the associations between AQP4 genetic variants and cognition and brain volumetrics.
∙ Α broad relationship was identified between AQP4 genetic variation and AD, with sleep as a potential modifier.
Details
- Title
- Evidence for direct and sleep-moderated relationships between aquaporin-4 genetic variants and Alzheimer's disease phenotypes
- Authors/Creators
- Tenielle Porter - Curtin UniversityAyeisha Milligan Armstrong - Curtin UniversityEleanor K O'Brien - Edith Cowan UniversityVincent Doré - Edith Cowan UniversityPierrick Bourgeat - Australian e-Health Research CentreMitchell Turner - Edith Cowan UniversityPaul Maruff - The University of MelbourneChristopher C Rowe - Austin HealthBelinda M Brown - Murdoch UniversityVictor L Villemagne - Edith Cowan UniversityStephanie R Rainey-Smith - Edith Cowan UniversitySimon M Laws - Edith Cowan UniversityAIBL Research Group
- Publication Details
- Alzheimer's & dementia, Vol.22(6), e71516
- Grant note
- Alzheimer's Drug Discovery Foundation GNT2001320 / the NHMRC Alzheimer's Association (USA) GNT1161706 / the NHMRC GNT1197315 / NHMRC Investigator
- Identifiers
- 991005886493907891
- Copyright
- ©2026 The Author(s).
- Murdoch Affiliation
- Research and Innovation Office; Centre for Healthy Ageing
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: SDGs in the Output
Metrics
1 Record Views